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Abstract
Obesity is a chronic disease responsible 
for comorbidity and excess mortality, and 
is considered an independent risk factor for 
cardiovascular pathology development. Most 
cardiovascular disease can be prevented by 
tackling behavioural risk factors, such as 
a sedentary lifestyle, unhealthy diet, and 
obesity. Taraxacum officinal is a perennial plant 
belonging to the Asteraceae family, commonly 
used for these medicinal characteristics. 
It has diuretic, anti-tumour, antioxidant, 
anti-inflammatory, hepatoprotective and 
immunostimulant properties. The aim of this 
study was to evaluate the lipid-lowering and 
cardioprotective effect of Taraxacum officinal 
aqueous extract in Wistar rats on hyper-
fatty diets. A total of 24 rats weighing 200 ± 
6.8 g were divided into three lots: healthy 
control (HC) receiving a standard diet, obese 
control (OC) receiving a cafeteria diet without 
treatment and the third load (TL) receiving a 
cafeteria diet and treated for 20 days with 200 
mg/kg Taraxacum officinal aqueous extract. The 
results showed that the cafeteria diet induced 
obesity in rats compared to the control group, 
characterized by hyperglycaemia (148.75 mg/
dL), hypertriglyceridemia (59 mg/dL) and 
hypercholesterolemia (160.67 mg/dL) with 
an increase in total lipids (0.39 g/g of tissue) 
associated with a state of oxidative stress 
in the cardiac tissue. Oral administration 
of the aqueous extract of Taraxacum officinal 
improved the lipid profile in serum and 
tissue. The findings showed a drop in blood 
sugar (1.02 mg/dL), total cholesterol (135 mg/
dL), LDL cholesterol, (67 mg/dL), triglycerides 
(36 mg/dL), total lipids (1.37g/g of tissue), 
and lipid peroxidation MDA (0.25 ± 0.02 
μmoL/g protein), and an increase in the level 
of GSH (0.51 nM /mg protein) in treated rats 
compared to the controls. In conclusion, the 
results obtained showed the effectiveness 
of the aqueous extract of Taraxacum 
officinal against dyslipidemia, obesity, and 
hyperglycaemia. The plant was shown to have 
both cardioprotective and antioxidant effect.
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Introduction
The key risk factors for cardiac disease 
and stroke are unhealthy diet, lack of 
physical activity, smoking and excessive 
alcohol intake. The consequences of 
lifestyle risk factors can affect people 
with hypertension, hyperglycaemia, 
hyperlipidaemia, excessive body weight 
and obesity. Obesity is the state of an 
organism with excess adiposities or 
excess fat mass resulting from a positive 
energy balance, in proportions that may 
have negative health effects. Visceral 
and massive obesity is a well-established 
risk factor for high blood pressure 
(hypertension), coronary heart disease 
and excess cardiovascular mortality 
(Corcos, 2012). The risk of coronary artery 
disease in obese and overweight people 
is partially explained by the frequent 
coexistence of other cardiovascular risk 
factors. Studies have also shown that 
there is a longitudinal linear relationship 
between obesity and coronary artery 
disease (Jousilahti et al., 1996).
Obese subjects are often distinguished 
by a dyslipidemic state in which 
plasma triglycerides are increased, 
HDL-C concentrations are lowered, 
and LDL apolipoprotein (Apo B-100) 
concentrations are increased. Hence 
central fat distribution plays a significant 
role in lipid abnormalities (Despres 
and Lemieux, 2006). The main risk of 
these pathologies is the appearance 
of cardiovascular disease through the 
formation of atheroma plaques that 
gradually block the arteries, causing 
atherosclerosis. Hypertension, coronary 
insufficiency, stroke, venous thrombosis 
and pulmonary embolism are major 
cardiovascular diseases associated with 
obesity. Another disorder is heart failure, 
which results from fatigue of the heart 
caused by excess body weight and the 
associated complications (Must et al., 
1999; Hensrud and Klein, 2006). Given 
the side effects of surgery and the harmful 
effects of synthetic drugs on weight loss, 
natural products are a better option in 
the treatment of excessive body weight, 
obesity and other medical disorders due 
to their efficacy (James, 2017).
Taraxacum officinal is a perennial 
plant belonging to the Asteraceae family, 
commonly used for its medicinal 
characteristics. It has diuretic, anti-
tumour, antioxidant, anti-inflammatory, 
and hepatoprotective activity (Baba et 
al., 1981; Kisiel and Barszcz, 2000; Hu 
and Kitts, 2003; Jeon et al., 2008). The aim 
of this study was to evaluate the lipid-
lowering and cardioprotective effect of 
Taraxacum officinal aqueous extract in 
obese Wistar rats.
Materials and methods
Aqueous extract preparation 
A total of 10 g powdered leaves 
dissolved in 150 ml distilled water 
was heated to reflux for 2 hours. After 
cold filtration; this filtrate was then 
evaporated to dryness reduced to 65°C 
using a rotating evaporator.
Animals and Obesity induction
The experiment included 24 Wistar 
rats weighing 200±6.8 g from the Pasteur 
Institute, Algeria. Rats were acclimatized 
for two weeks under the conditions of the 
Molecular and Cell Biology Department, 
El Oued University, Algeria: air 
temperature of 22±2 °C, 50% humidity 
and a normal photoperiod (12 h light/12 
h darkness).
To induce obesity, rats were given 
either a standard diet (control) or the 
cafeteria diet for a period of one month. 
The cafeteria diet is made up of 50% 
standard diet and 50% sausage mixture, 
dry cookies, cheese, chips, peanut, and 
chocolate in the ratio 2:2:1:1:1 (Darimont 
et al., 2004). Obesity perception in rats 
was confirmed by monitoring body 
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weight gain and the quantity of food 
consumed during one month.
Treatment of animals
After one month, non-obese rats 
served as the healthy control lot (HC) 
receiving a standard diet with tap water. 
Obese rats were divided into two groups: 
obese control (OC) receiving a cafeteria 
diet without treatment, and the third load 
(TL) receiving a cafeteria diet and treated 
for 20 days with 200 mg/kg Taraxacum 
officinale aqueous extract.
Sacrifice, blood and organs samples
Rats were anesthetized with 
chloroform (94%) and sacrificed after 
12 hours of fasting. Blood samples were 
collected in EDTA and dry tubes. After 
centrifugation at 3000 rpm for 15 minutes, 
serum and plasma were collected and 
stored for lipid parameter determination.
The liver, heart, adipose tissue, and 
kidneys were carefully removed after 
dissection, rinsed with saline solution, 
and weighed. Organ homogenates 
were used to evaluate oxidative stress 
parameters and to measure tissue lipids. 
Dosage of serum and tissue 
lipid parameters
Triglycerides (TG), total cholesterol, 
HDL-cholesterol and glutamate-oxalo-
acétate-transaminase (GOT) were 
determined using the colorimetric method 
by a type autoanalyzer (BIOLIS24j) with 
the appropriate reagent package for 
each parameter. LDL-cholesterol was 
determined using the direct calculation 
method according to the formula of 
Friedwald et al. (1972): LDL-C = Total 
cholesterol - [HDL-C + TG / 5].
For the quantification of total lipids at 
the tissue level, we used cold extraction 
with a mixture of polar/apolar solvents 
(chloroform/methanol) according to the 
Folch et al. (1957) method. 
Oxidative stress parameters
To prepare homogeneous organs, 1 
gram of tissue (heart, liver, kidney and 
adipose tissue) from each rat was used 
from the various study groups. After 
grinding and homogenizing the tissues 
in TBS (Tris 50 mM, NaCl 150 m M, pH 
7.4), samples were centrifuged at 3000 
r/min for 15 min. The supernatant was 
recuperated to perform the oxidative 
stress parameter assay.
The thiobarbituric acid method 
(TBA; Yagi, 1976) is used to determine 
malondialdehyde (MDA) which reacts 
with TBA to give pink absorbing 
chromophores at 532 nm. Glutathione 
(GSH) was determined by a SHIMATZU 
type spectrophotometer using the 
colorimetric method (Weckbecker and 
Cory, 1988); the measurement of optical 
density was the result of the formation 
of 2-nitro-5 mercocapturic acid from the 
reduction of dithio-bis2 nitrobenzoic 
acid. Absorbance was set at 412 nm.
Statistical analysis
The results are presented as mean ± 
standard deviation. The comparison of 
means was carried out by the Student 
t-test using MINITAB and EXCEL 
software. Differences were considered 
significant at P<0.05.
Results 
Food consumption, weight gain and 
total fat content in tissue 
The results obtained are presented in 
Table 1. 
During treatment, there was no 
difference in the amount of food 
consumed by rats receiving the cafeteria 
diet compared to the control lot. Treatment 
with Taraxacum officinal aqueous extract 
significantly decreased food intake in 
obese rats compared to the control (HC). 
The results showed that the cafeteria diet 
induced an increase in weight gain and 
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tissue lipid content in obese control rats 
relative to the control group. In the Wistar 
rat, consuming a hyperlipidic and high-
calorie diet increases food intake, body 
weight and induces lipid accumulation 
in adipose tissue (Milagro et al., 2006; 
Bouanane et al., 2010; Benkalfat et al., 
2011). The accumulation of adipose tissue 
and its lipid enrichment is a feature of 
the cafeteria diet induced by obesity 
(Caluwaerts et al., 2007). Lipotoxicity 
results from an ectopic accumulation of 
lipids in the liver, and the muscles and 
heart are involved in the insulin resistance 
of these different tissues (Despres and 
Lemieux, 2006).
However, the administration of Tarax-
acum officinal aqueous extract causes a 
considerable reduction in weight gain 
and in tissue lipid content in the treated 
group (TL) compared to the obese control 
group (OC). This decrease in weight may 
be due to several mechanisms. Accord-
ing to Kajimura and Saito, (2014), most 
natural anti-obesity products (medicinal 
plants) regulate body weight through an 
increase in compulsory energy expend-
iture by transforming energy from food 
into heat.
Blood glucose and lipid content
The results showed a significant 
increase in glycaemia, triglycerides, 
cholesterol and LDL-C levels, and a 
decrease in HDL-C levels in the OC 
group compared to the control group C. 
However, significant decreases (P<0.01) in 
glucose and serum lipids were observed 
in the treated group (TL) (Table 2).
Obesity caused by the cafeteria diet 
induced an increase in blood sugar. 
Studies have reported that rats with a 
diet high in fat develop insulin resistance 
and confirmed hyperglycaemia (Stubbs 
and Wickremesekera 2002; Bihan et al., 
2007). The hyper lipid diet increases 
glucose production by reducing 
insulin suppression and increasing 
Table 1. Food consumption and weight gain in control rats, obese controls and treated rats (mean ± 
standard error).
Parameter HC OC TL
Food consumption (g/d/rat) 28.375±0.95 29.483±0.54NS 24.583±0.73***,c
Weight gain (g/d) 0.325±0.01 0.677±0.13* 0.021±0.1*, c
Fat total content in tissue (g) 0.152±0.01 0.49±0.02*** 0.143±0.05NS,c
Comparison with control group (C): *** P<0.001, with obese control group (OC):
aP<0.05; cP< 0.001, n=8 rats
Table 2. Plasma concentration of glucose, triglycerides (TG), cholesterol (CL), HDL and LDL in the 
control and treated groups (mean ± standard error).
Parameter Control group Obese control group Treated group
Glycaemia (mg/dL) 97.75±4.37 148.75±4.35*** 102.33±5.36NS,a
Triglyceride (mg/dL) 43±7.94 59±3.51* 36.67±3.33NS,a
Cholesterol (mg/dL) 142±7.09 160.67±1.86** 135.33±4.48NS,a
HDL (mg/dL) 60.66±0.33 52.3±3.68NS 61 ±4.58NS
LDL (mg/dL) 78.07±5.64 96.57±2.35NS 67±0.577***,c
Comparison with control group (C): ***P<0.001, **P<0.01, *P<0.05 with obese control group (OC): 
aP<0.05; cP< 0.001, n=8 rats
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gluconeogenesis (Martínez-Gonzalez et 
al., 1989), resulting in elevated plasma 
glucose levels. Studies of Taraxacum 
officinal extracts revealed that it can 
stimulate insulin release into the β cells of 
the pancreas, thus neutralizing the effects 
of hyperglycaemia (Hussain et al., 2004; 
Schütz et al., 2006).
The results indicate an observed 
hyperlipidaemia in OC rats, which can 
be explained by the high lipid content in 
the diet. Obesity is also distinguished by 
an expansion of the adipose tissue mass 
and an increase in the cholesterol and 
triglyceride storage capacity (Benkalfat 
et al., 2011), which raises the risk of 
cardiovascular disease. Kim et al. (2000) 
identified that triglyceride accumulation 
was associated with insulin resistance as 
a result of insulin signalling disruption in 
tissues.
The results also showed a significant 
increase in LDH cholesterol. The 
increased serum LDH activity is 
a precursor for necrosis of cardiac 
tissue (Ben Amor et al., 1999). The 
administration of aqueous extract of 
Taraxacum officinale decreased the serum 
level of LDH thus inducing a decrease in 
cardiac tissue necrosis. In rats, Taraxacum 
officinal leaf extract has been shown to 
reduce serum glucose, cholesterol and 
triglyceride levels, possibly due to the 
elevation of protein kinase activated 
by adenosine monophosphate (AMPK) 
in the liver, resulting in a significant 
decrease in the accumulation of lipids 
and an improvement in sensitivity to 
insulin (Davaatseren et al., 2013). Several 
studies have reported the presence 
of saponins in the Taraxacum officinal 
aqueous extract (Mir et al., 2013), the 
latter having anti-hyperlipidaemia and 
anti-hypercholesterolemia effect (Özlem 
and Giuseppe, 2007).
GOT levels and oxidative stress 
biomarkers in cardiac tissue
The results obtained show an increase 
in the serum activity of GOT in the 
obese control group compared to the 
control group (P<0.01; Figure 1). The 
increase in serum transaminase activity 
(GOT) in obese rats is considered to 
be a biomarker of hepatic dysfunction 
or cardiac damage (Fiacre et al., 2002; 
Dieusaert, 2005) caused by the hyper fat 
diet. However, GOT was reduced after 
the administration of Taraxacum offilcinal 
aqueous extract, and this effect could be 
interpreted as a protective effect of the 
cardiovascular system.
The results show a significant 
increase in the malondialdehyde (MDA) 
concentration (Table 3) in cardiac tissue 
Figure 1. Activity of GOT transaminases in control 
groups and treated group.
Comparison with control group (C): ** P<0.01, with obese control 

















Table 3. Cardiac tissue concentrations of malondialdehyde (MDA) and reduced glutathione (GSH) in the 
control, obese control and treated group (mean ± standard error).
Control Obese control Treated group
MDA (μmoL/g tissue) 0.322±0.05 0.522±0.058* 0.232±0.026*,b
GSH (nM/mg protein) 0.168±0.015 0.089±0.007** 0.367±0.053*,b
Comparison with control group (C): ** P<0.01, * P<0.05 with obese control group (OC): bP< 0.01, n=8 rats
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in obese controls compared with healthy 
controls, which favours apparent 
oxidative stress. 
These results can be explained by 
lipid self-oxidation (Saka et al., 2011), 
likely induced by obesity. A high-fat diet 
also leads to mitochondrial dysfunction 
correlated with oxidative stress 
(Yuzefovych et al., 2013). Nevertheless, 
a significant decrease in MDA was 
observed in the Taraxacum officinal extract 
treated group, showing the antioxidant 
effect of the plant (Hagymasi et al., 2000; 
Choi et al., 2010; Gonzalez-Castejon et al., 
2012).
The results of the statistical analysis 
show evidence a significant reduction of 
GSH in the cardiac tissue in obese rats. 
On the one hand, this reduction can be 
viewed as an increase in its use by liver 
cells, while on the other, by a reduction 
in the synthesis of GSH or increase of 
its degradation during oxidative stress 
(Loven et al., 1986). 
GSH can be associated with many 
pathways in vascular physiology and 
pathology. Oxyradicals and peroxides 
are considered to have strong effects on 
platelets, endothelial cells and smooth 
vascular muscle cells (Hennig and Chow, 
1988; Rubanyi, 1988). As a product of 
oxidative stress, endothelial dysfunction 
has been identified as a possible 
pathological vector in the formation 
of atherosclerosis, and in vascular 
sound alterations and permeability 
(Boissonneault et al., 1990).
However, a reduction in glutathione 
was observed in obese rats after 
administration of the aqueous extract of 
Taraxacum officinal. Ivanov, (2014) reported 
that Taraxacum officinal is a good source of 
biologically active compounds and has 
desirable antioxidant properties. Raising 
glutathione levels fights the oxidation of 
fatty acids in the bloodstream, including 
cholesterol, thereby delaying the process 
of plaque formation in the arteries, which 
is the underlying cause of most heart 
problems (Stamler and Slivka, 1996). 
Additionally, GSH plays an important 
role in leukotrien and prostaglandin 
formation and metabolism, which 
have a potential role in coronary artery 
constriction, causing ionotropic damage 
to cardiac muscle. The results also showed 
that the Taraxacum officinal aqueous 
extract improved the state of oxidative 
stress in rats, confirming that this plant 
could contribute to the protection of the 
heart against pathologies linked to the 
deleterious effects of reactive oxygen 
species.
Conclusions
Taraxacum officinal aqueous extract 
had a cholesterol-lowering, hypotriglyc-
eridemic, hypoglycaemic and cardiopro-
tective effect in Wistar rats.
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Pretilost je kronična bolest koja je odgo-
vorna za komorbiditet i prekomjernu smrt-
nost te se smatra neovisnim čimbenikom ri-
zika za razvoj kardiovaskularne patologije. 
Većinu kardiovaskularnih bolesti moguće 
je spriječiti rješavanjem faktora rizika pona-
šanja; sjedilačkog načina života, nezdrave 
prehrane i pretilosti. Taraxacum officinal je vi-
šegodišnja biljka koja pripada obitelji Astera-
ceae, a obično se rabi zbog svojih medicinskih 
svojstava. Ima diuretičko, protutumorsko, 
antioksidativno, protuupalno, hepatoprotek-
tivno i imunostimulacijsko djelovanje. Cilj je 
ove studije bio procijeniti učinak snižavanja 
lipida i kardioprotektivni učinak vodenog 
ekstrakta Taraxacum officinal u štakora soja 
wistar na vrlo masnoj prehrani. 24 štakora 
težine 200 ± 6,8 g podijeljeno je u 3 skupine: 
zdravu kontrolnu (HC) koja je primala stan-
dardnu prehranu, pretilu kontrolnu (OC) 
koja je primala „kantinsku“ hranu bez terapi-
je i treću opterećenu skupinu (TL) koja je pri-
mala „kantinsku dijetu“ i terapiju tijekom 20 
dana s 200 mg/kg vodenog ekstrakta Taraxa-
cum officinal. Dobiveni rezultati su pokazali 
da je „kantinska dijeta“ dovela do pretilosti 
štakora u usporedbi s kontrolnom skupinom 
okarakteriziranom hiperglikemijom (148,75 
mg/dL), hipertrigliceridemijom (59 mg/dL) 
i hiperkolesterolemijom (160,67 mg/dL) uz 
povećanje ukupnih lipida (0,39 g/g tkiva) 
povezano sa stanjem oksidativnog stresa u 
srčanom tkivu. Oralna primjena vodenog ek-
strakta Taraxacum officinal poboljšala je lipidni 
profil u krvi i tkivu. Nalazi su pokazali pad 
šećera u krvi (1,02 mg/dL), ukupnog koleste-
rola (135 mg/dL), LDL kolesterola, (67 mg/
dL), triglicerida (36 mg/dL), ukupnih lipida 
(1,37 g/g tkiva) i peroksidacije lipida MDA 
(0,25 ± 0,02 μmoL/g proteina) te povećanje 
razine GSH (0,51 nM/mg proteina) u štakora 
koji su primali terapiju u usporedbi s kontrol-
nim skupinama. Zaključno, dobiveni rezulta-
ti dokazali su učinkovitost vodenog ekstrakta 
Taraxacum officinal protiv dislipidemije, preti-
losti i hiperglikemije. Biljka ima kardiopro-
tektivni i antioksidativni učinak.
Ključne riječi: bolest srca, dislipidemija, 
pretilost, oksidativni stres, faktor rizika, Taraxacum 
officinal
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